Literature DB >> 8083604

Regulation of HIV expression by viral genes and cytokines.

E Vicenzi1, G Poli.   

Abstract

The human immunodeficiency virus (HIV) is the causative agent of the acquired immunodeficiency syndrome (AIDS), a leading cause of death among young individuals. As a complex pathogenic retrovirus, HIV is characterized in vitro and in vivo by the ability to establish either a latent or productive infection of CD4+ T lymphocytes and mononuclear phagocytes (MPs). Viral latency and expression are under the control of both viral genes and several host-related factors. Among these latter, several proinflammatory and immunoregulatory cytokines profoundly affect HIV replication in T lymphocytes and MPs in vitro. Because many of these cytokines have been found to be elevated in HIV-infected individuals, it is likely that they act as regulators of viral expression in vivo. Both viral genes and cytokines regulate transcriptional and posttranscriptional steps in HIV replication. Thus, it is likely that common regulatory pathways between these two distinct classes of regulator molecules will be identified in the near future and will provide potential targets for pharmacologic intervention and treatment of HIV disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083604     DOI: 10.1002/jlb.56.3.328

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?

Authors:  Darrell H S Tan; Rupert Kaul; Sharon Walsmley
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

2.  Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection.

Authors:  R T Kilani; L J Chang; M I Garcia-Lloret; D Hemmings; B Winkler-Lowen; L J Guilbert
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding.

Authors:  F Zara; R E Nappi; R Brerra; R Migliavacca; R Maserati; A Spinillo
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

4.  Differential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonates.

Authors:  M P Nair; K C Chadha; I Stadler; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 5.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

6.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

Authors:  C Rinaldo; X L Huang; Z F Fan; M Ding; L Beltz; A Logar; D Panicali; G Mazzara; J Liebmann; M Cottrill
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.

Authors:  Atsushi Okumura; Tim Alce; Barbora Lubyova; Heather Ezelle; Klaus Strebel; Paula M Pitha
Journal:  Virology       Date:  2007-12-20       Impact factor: 3.616

8.  Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial.

Authors:  Darrell H S Tan; Janet M Raboud; Rupert Kaul; Beatriz Grinsztejn; Pedro Cahn; Sharon L Walmsley
Journal:  Trials       Date:  2010-11-24       Impact factor: 2.279

Review 9.  An Outlook on the Etiopathogenesis of Pulmonary Hypertension in HIV.

Authors:  Jaimee J Palakeel; Mazin Ali; Phani Chaduvula; Sanika Chhabra; Smriti Lamsal Lamichhane; Vaiishnavi Ramesh; Collins O Opara; Farhana Yaqoob Khan; Gargi Kabiraj; Humaira Kauser; Jihan A Mostafa
Journal:  Cureus       Date:  2022-07-28

10.  Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.

Authors:  Darrell H S Tan; Janet M Raboud; Leah Szadkowski; Beatriz Grinsztejn; José Valdez Madruga; Maria Ines Figueroa; Pedro Cahn; Simon E Barton; Amanda Clarke; Julie Fox; Wendy Zubyk; Sharon L Walmsley
Journal:  J Antimicrob Chemother       Date:  2019-02-01       Impact factor: 5.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.